Nu-Med Plus (NUMD) Retained Earnings (2011 - 2025)
Nu-Med Plus (NUMD) reported Retained Earnings of -$9.9 million for Q4 2025, down 0.57% on a YoY basis from -$10.0 million in Q4 2024, and little changed sequentially from -$9.9 million in Q3 2025.
Nu-Med Plus (NUMD) Retained Earnings (2011 - 2025) Analysis & Trends
Nu-Med Plus (NUMD) has 15 years of Retained Earnings data on file, last reported at -$9.9 million in Q4 2025.
- For the quarter ending Q4 2025, Retained Earnings fell 0.57% year-over-year to -$9.9 million; the trailing twelve-month figure through Dec 2025 stood at -$9.9 million (down 0.57% YoY), and the FY2025 full-year result was -$9.9 million, down 0.57% from the prior year.
- Retained Earnings held at -$9.9 million in Q4 2025, from -$9.9 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $9.6 million in Q3 2024 to a low of -$9.9 million in Q4 2025.
- A 5-year average of -$3.0 million and a median of -$9.6 million in 2021 frame the typical range for Retained Earnings.
- Across the five-year window, Retained Earnings slumped 254.17% in 2021 and soared 202.88% in 2022, its largest moves.
- Tracing NUMD's Retained Earnings over 5 years: stood at -$9.6 million in 2021, then jumped by 199.85% to $9.6 million in 2022, then tumbled by 202.82% to -$9.8 million in 2023, then declined by 0.7% to -$9.9 million in 2024, then declined by 0.57% to -$9.9 million in 2025.
- Business Quant data shows NUMD's Retained Earnings at -$9.9 million in Q4 2025, -$9.9 million in Q3 2025, and $9.6 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -6.31 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -583.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -4.10 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 6.91 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 14.62 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.63 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -1.40 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 5.32 Bn |
| 10 | Nu-Med Plus | 1.67 Mn | 1.67 Mn | - | -9.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -9.95 Mn |
| Sep 30, 2025 | -9.94 Mn |
| Jun 30, 2025 | 9.59 Mn |
| Mar 31, 2025 | -9.91 Mn |
| Dec 31, 2024 | -9.89 Mn |
| Sep 30, 2024 | 9.59 Mn |
| Jun 30, 2024 | -9.86 Mn |
| Mar 31, 2024 | -9.85 Mn |
| Dec 31, 2023 | -9.82 Mn |
| Sep 30, 2023 | 9.56 Mn |
| Jun 30, 2023 | -9.75 Mn |
| Mar 31, 2023 | -9.73 Mn |
| Dec 31, 2022 | 9.56 Mn |
| Sep 30, 2022 | -9.74 Mn |
| Jun 30, 2022 | 9.36 Mn |
| Mar 31, 2022 | 9.36 Mn |
| Dec 31, 2021 | -9.57 Mn |
| Sep 30, 2021 | -9.46 Mn |
| Jun 30, 2021 | 9.26 Mn |
| Mar 31, 2021 | -9.10 Mn |